Specific desensitizing treatment in drug allergy

Area of Science:

• Clinical Immunology
• Pharmacology
• Allergy and Clinical Immunology

Background:

• Drug allergies pose significant challenges in patient management.
• Limited treatment options exist for severe drug hypersensitivity reactions.
• Immunotherapy offers a potential strategy for managing drug allergies.

Purpose of the Study:

• To evaluate the efficacy and safety of specific desensitization treatment for drug allergies.
• To assess the feasibility of immunotherapy in patients with hypersensitivity to various drugs.

Main Methods:

• Fourteen patients with documented allergies to synthetic corticotrophin, insulin, pyramidon, penicillin, or iodine-containing contrast media were included.
• Specific desensitization was performed using graduated doses of the offending drug.
• Treatment outcomes and adverse reactions were closely monitored.

Main Results:

• Complete therapeutic success was achieved in 11 out of 14 patients (78.6%).
• Treatment was suspended in three cases due to pregnancy (pyramidon allergy) and severe adverse reactions (corticotrophin and penicillin allergies).
• No major complications were reported in successfully treated patients.

Conclusions:

• Specific drug desensitization via immunotherapy is a viable and effective treatment for drug allergies.
• The procedure requires highly qualified medical personnel and should ideally be conducted in a hospital setting.
• Careful patient selection and monitoring are crucial for successful immunotherapy outcomes.